Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2792 (LINC02792)

Target
LINC02792
Molecular classification
Long non-coding RNA, Intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2792 (LINC02792) is a member of the large class of non-protein coding RNAs known as long intergenic non-coding RNAs (lincRNAs)[1][3][5]. LincRNAs are defined as autonomous RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes[3][5]. While thousands of lincRNAs have been annotated in the human genome, only a subset have well-characterized biological functions, most of which are related to regulation of gene expression, modulation of chromatin states, and transcriptional control—often in a tissue-specific manner[3][5]. For many individual lincRNAs, including LINC02792, there are no published functional or disease associations or evidence of druggability, and they are not considered classical therapeutic targets such as receptors, enzymes, or transporters[1]. Key clarification: - There is no evidence LINC02792 is a therapeutic target or has drug interactions[1]. - Its designation as a lincRNA indicates its primary role as a non-coding RNA potentially involved in regulation rather than a protein or receptor[3][5].

Other names
LINC02792LOC105378810
02

Biological functions

Gene expression regulation (inferred for lincRNAs)[3][5]Chromatin remodeling (inferred for lincRNAs)[3][5]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2792 (LINC02792).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2792 (LINC02792).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call